Stand Up 2 Cancer (SU2C) Genomics-Enabled Medicine for Melanoma (GEMM) Trial
UID: 10638
Publisher(s): Stand Up To Cancer- Description
- Study Description from dbGaP: "The goal of the GEMM Trial is to ascertain if comprehensive and systematic interrogation of a patient's tumor molecular profile improves outcomes compared to the current practice of physician's choice for metastatic melanoma patients who have progressed following first line therapy. The data shared here includes tumor/normal exome and tumor RNAseq data for the trial patients, as well as archival data for a subset of patients."
CNV (NGS) Sequencing of 128 samples from 36 patients. - Local Expert
-
Access via dbGaP
Access to metadata regarding the specifics of this study
Accession #: phs001786.v1.p1 - Access Restrictions
-
Application Required
- Access Instructions
- Full access to this dataset in dbGaP requires authorization through an Authorized Access Portal which can be requested for either 'data download' or 'view only'. Individual level data download requires a project request. With dbGaP DataBrowser approval, users may view the compilation of individual-level data of general research use. Upon approval, data can be downloaded.
Publicly available data such as data dictionaries, variable summaries, documents and truncated analysis are available the public download site FTP link - Associated Publications
- Data Type
- Data Tool(s)
-
CNV
Do you have or know of a dataset that should be added to the catalog? Let us know!